Concepedia

Christos Hatzis

CH

Statistics

Publications

112

Citations

11.5K

H-Index

51

Active since

1990

Affiliations

Yale Cancer Center(Current)

Yale University

The University of Texas MD Anderson Cancer Center

University of Crete

Nuvera Biosciences (United States)

Christos Hatzis is an author at Yale Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

1990–2023

112

Publications

112

Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

W. Fraser Symmans, Florentia Peintinger, Christos Hatzis et al. · Journal of Clinical Oncology · 2007 · 1.7K citations · Full text

Medicine, Oncology, Breast Oncology +16

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

Zhiguang Li, Weida Tong, Živana Težak et al. · Nature Biotechnology · 2010 · 915 citations · Full text

Life Sciences, Bioinformatics, Molecular Genetics +7

A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer

Christos Hatzis · JAMA · 2011 · 722 citations

Medicine, Biostatistics, Oncology +17

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

W. Fraser Symmans, Caimiao Wei, Rebekah Gould et al. · Journal of Clinical Oncology · 2017 · 718 citations · Full text

Medicine, Oncology, Breast Oncology +16

Immunological differences between primary and metastatic breast cancer

Borbála Székely, Veerle Bossuyt, Xiaofeng Li et al. · Annals of Oncology · 2018 · 374 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 112